Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas
Kavindra Abeyratne(The University of Adelaide), Kate D. Lynch(Royal Adelaide Hospital), Simon Ghaly(UNSW Sydney), Martin Harb(Liverpool Hospital), Karen Bensted(St George Hospital), Susan J. Connor(Liverpool Hospital), Jane M. Andrews(Health Net)
Cited by 1
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123